97165 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
METHODS AND COMPOSITIONS TO MODULATE T CELL METABOLISM, FUNCTION, AND FATE
#2METHODS OF TREATING CACHEXIA
#3METHODS AND COMPOSITIONS FOR TREATMENT OF ENDOTHELIN B RECEPTOR EXPRESSING TUMORS
#4NEUTRALIZING ANTIBODIES TO HUMAN ENDOTHELIN
#5LEPTIN COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME TO SUPPORT WEIGHT LOSS AND/OR MAINTENANCE
#6COMBINATIONS OF ANTI-GIP ANTIBODIES AND INCRETINS AND USES THEREOF
#7MODULATORS
#8NANOBODY THAT SPECIFICALLY BIND TO VASPIN, AND COMPOSITIONS COMPRISING SAME FOR PREVENTING OR TREATING OSTEOARTHRITIS
#9ANTI-CORTICOTROPIN-RELEASING HORMONE ANTIBODIES AND POLYCYSTIC OVARY SYNDROME
#10ANTI-ADRENOMEDULIN NON-NEUTRALIZING ANTIBODY, METHOD FOR PREPARING SAME, AND USE THEREOF
#11NEUTRALIZATION OF ACYL-COA BINDING PROTEIN FOR THE TREATMENT OF CARDIAC DYSFUNCTION
#12COMPOSITIONS AND METHODS FOR TREATING POSTURAL TACHYCARDIA SYNDROME
#13MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
#14LEPTIN COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME TO SUPPORT WEIGHT LOSS AND/OR MAINTENANCE
#15COMPOUNDS USEFUL TO TREAT METABOLIC DISORDERS
#16METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING ANTAGONISTIC BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR)/GLP-1 RECEPTOR AGONIST FUSION PROTEINS
#17COMPOSITIONS AND METHODS FOR TREATING ISCHEMIC HEART DISEASE
#18NUCLEIC ACIDS ENCODING ANCHOR MODIFIED ANTIBODIES AND USES THEREOF
#19ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE
#20MONOCLONAL ANTIBODIES AGAINST ENDOTROPHIN AND THE USE THEREOF
#21METHOD AND MEANS FOR MODULATING B-CELL MEDIATED IMMUNE RESPONSES
#22SUPER LONG-LASTING GLP1 OR GLP1/GIP ANALOGUE DRUG FOR TYPE-2 DIABETES AND OBESITY
#23MICROENVIRONMENTAL DETERMINANTS OF CLONAL HEMATOPOIESIS EXPANSION RATE
#24ANTI-FSH ANTIBODIES FOR NEURODEGENERATIVE DISEASES
#25SYNCITIN-1 FUSION PROTEINS AND USES THEREOF FOR CARGO DELIVERY INTO TARGET CELLS
#26RECOMBINANT ANTIBODY, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, AND USES THEREOF IN TREATING CANCERS
#27ANTI-CORTICOTROPIN-RELEASING HORMONE ANTIBODIES AND USE IN CONGENITAL ADRENAL HYPERPLASIA
#28MATERIALS AND METHODS FOR TREATING STRESS-RELATED DISORDERS AND CANCER
#29NOVEL T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME
#30MODULATORS OF INTEROCEPTION
#31DEPLETION OF FNDC5 REDUCES CANCER INDUCED MUSCLE LOSS/CACHEXIA
#32MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
#33COMPOSITIONS AND METHODS FOR TREATING ISCHEMIC HEART DISEASE
#34SHBG AND IBP4 ANTIBODIES AND METHODS USING SAME
#35ANTIGENIC PEPTIDES DERIVING FROM UROCORTIN 3 AND USES THEREOF FOR THE DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES
#36Enzyme-linked immunosorbent assay (ELISA) method and monoclonal antibody for giant panda relaxin-3 (RLN3)
#37MONOCLONAL ANTIBODIES AGAINST VETERINARY PROGASTRIN-LIKE MOLECULES AND THEIR USES
#38Antibody, Kit, Detection Method and Sample Analyzer for Detecting Thyroid Stimulating Hormone
#39LEPTIN ANTIBODIES AND METHOD OF REDUCING LEPTIN
#40DEVICES, SYSTEMS AND METHODS FOR DETECTION OF BETA SUBUNIT OF LUTEINIZING HORMONE
#41RESISTIN-SPECIFIC ANTIBODY AND USE THEREOF
#42HUMANIZED ANTI-PACAP ANTIBODIES AND USES THEREOF
#43PROTEIN SIGNATURES FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL INFECTIONS
#44METHODS AND COMPOSITIONS FOR INCREASING N-ACETYLGLUCOSAMINIDASE ACTIVITY IN THE CNS
#45INHIBIN ANTIBODIES AND CANCER TREATMENT
#46COMPOSITIONS AND METHODS FOR DETECTING AND TREATING GASTRIC CANCER
#47NOVEL MONOCLONAL ANTIBODIES DIRECTED AGAINST L-THYROXINE AND DIAGNOSTIC USES THEREOF
#48PEPTIDE IMMUNOGENS TARGETING ISLET AMYLOID POLYPEPTIDE (IAPP) AND FORMULATIONS THEREOF FOR PREVENTION AND TREATMENT OF DISORDERS RELATED TO AGGREGATED IAPP
#49ANTI-GROWTH HORMONE ANTIBODY
#50ASSAY METHOD FOR RELAXIN
#51METHODS AND SYSTEMS FOR DETECTING PEPTIDE AGGREGATES
#52METHOD OF MODULATING THE ACTIVITY OF ADRENOMEDULLIN IN A SUBJECT IN NEED OF THERAPEUTIC INTERVENTION FOR ORGAN DYSFUNCTION OR ORGAN FAILURE ASSOCIATED WITH ADRENOMEDULLIN (ADM) ACTIVITY BY ADMINISTERING AN ANTI-ADRENOMEDULLIN (ADM) ANTIBODY OR AN ANTI-ADM FRAGMENT TO THE SUBJECT
#53METHODS AND MEANS FOR THE PRODUCTION OF IG-LIKE MOLECULES
#54TISSUE-DIRECTED ANTIBODIES AND METHODS OF USING THE SAME
#55NUCLEIC ACIDS ENCODING ANCHOR MODIFIED ANTIBODIES AND USES THEREOF
#56ANTIBODIES SPECIFIC FOR STRUCTURALLY DISORDERED SEQUENCES
#57MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
#58METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING ANTAGONISTIC BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR)/GLP-1 RECEPTOR AGONIST FUSION PROTEINS
#59COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES BY INHIBITING FSH
#60METHODS OF CELL THERAPIES
#61POLYPEPTIDES WITH ALTERED BINDING TO NEONATAL FC RECEPTOR (FCRN) AND METHODS OF USE
#62METHODS OF TREATING OBESITY, DIABETES, AND LIVER DYSFUNCTION
#63ANTI-CGRP COMPOSITIONS AND USE THEREOF
#64PARATHYROID HORMONE RECEPTOR 1(PTH1R) ANTIBODIES AND USES THEREOF
#65Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using Same
#66MONOCLONAL ANTIBODY AGAINST D-DIMER AND DIAGNOSIS AGENT FOR DETECTING D-DIMER, CROSSLINKED FIBRIN AND ITS DERIVATIVES CONTAINING D-DIMER BY USING THE ANTIBODY
#67COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ESOPHAGEAL CANCER
#68Methods and Compositions for Treating Aging-Associated Impairments with Trefoil Factor Family Member 2 Modulators
#69OXYNTOMODULIN BINDING MOLECULES, AND USES THEREOF
#70Weight Loss Regimen
#71COMPOSITION FOR CONTROLLED OVARIAN STIMULATION
#72COMPOSITIONS AND METHODS FOR DETECTING AND TREATING OVARIAN CANCER
#73TESTOSTERONE-SPECIFIC AFFIBODY AND USES THEREOF
#74METHODS OF TREATING SEVERE INSULIN RESISTANCE BY INTERFERING WITH GLUCAGON RECEPTOR SIGNALING
#75METHODS FOR TREATING INFLAMMATION USING ANTIBODIES TO KALLIDIN AND DES-ARG10-KALLIDIN
#76Dermal Patch for Transdermal Administration of Ghrelin Pathway Blocker
#77HIGHLY SENSITIVE PARTICLE ENHANCED ASSAY FOR THE QUANTIFICATION OF NT-PROBNP
#78Leptin antibodies and method of reducing leptin
#79Anti-ADM-antibodies binding to the free N-terminus for accelerated transition of ADM-Gly to bio-ADM in patients with ADM-Gly/ bio-ADM ratio above a threshold and combination with vitamin C
#80THERAPEUTIC AGENTS AND USES THEREOF
#81Methods and means for the production of Ig-like molecules
#82MONOCLONAL ANTIBODIES DIRECTED TO PEPTIDE IN THE CONTEXT OF MHC AND METHODS OF MAKING AND USING MONOCLONAL ANTIBODIES
#83METHODS OF SCREENING ANTIGEN-BINDING MOLECULES BY NORMALIZING FOR THE CONCENTRATION OF ANTIGEN-BINDING MOLECULE
#84ANTIBODIES BINDING SPECIFICALLY TO NT-PROBNP AND USE THEREOF
#85NOVEL COMPOUNDS CAPABLE OF ANTAGONIZING ISLET AMYLOID POLYPEPTIDE (IAPP) INDUCED BETA-CELL DAMAGE AND IMPAIRED GLUCOSE TOLERANCE
#86COMPOUNDS AND METHODS TARGETING HUMAN AND MOUSE INSL5
#87ILT7 BINDING MOLECULES AND METHODS OF USING THE SAME
#88ANTI-ADRENOMEDULLIN (ADM) BINDER FOR USE IN THERAPY OF PATIENTS IN SHOCK
#89BISPECIFIC PROTEIN
#90MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
#91Method for improving affinity of antibody for antigen and use thereof
#92Method for improving affinity of antibody for antigen and use thereof
#93COMPOSITIONS AND METHODS FOR ANTI-PACAP ANTIBODIES
#94Method for improving affinity of antibody for antigen and use thereof
#95GLP1R AGONIST NMDAR ANTAGONIST CONJUGATES
#96ANTI-ACTH ANTIBODIES AND USE THEREOF
#97MONOCLONAL ANTIBODY AND POLYCLONAL ANTIBODY AND OXYTOCIN QUANTIFICATION METHOD BASED ON SAME
#98Anti-CGRP Antibody Formulation
#99PEPTIDE IMMUNOGENS TARGETING PITUITARY ADENYLATE CYCLASE-ACTIVATING PEPTIDE (PACAP) AND FORMULATIONS THEREOF FOR PREVENTION AND TREATMENT OF MIGRAINE
#100ANTI-PACAP ANTIBODIES AND USES THEREOF
#101ANTI-ADRENOMEDULLIN (ADM) ANTIBODY OR ANTI-ADM ANTIBODY FRAGMENT OR ANTI-ADM NON-IG SCAFFOLD FOR USE IN THERAPY OR PREVENTION OF SHOCK
#102LONG LIFE POLYPEPTIDE BINDING MOLECULES
#103IGF-1R MONOCLONAL ANTIBODIES AND USES THEREOF
#104NOVEL PEPTIDE HORMONES
#105Oral Delivery Compositions for Obesity Management
#106COMPOSITIONS AND METHODS FOR TREATING OBESITY AND HYPERPHAGIA
#107Anti-thyroglobulin t cell receptors
#108METHODS AND COMPOSITIONS FOR INCREASING ENZYME ACTIVITY IN THE CNS
#109SUPERAGONIST POLYPEPTIDE ANALOGS OF ADRENOMEDULLIN AND INTERMEDIN PEPTIDE HORMONES
#110ANTI-MÜLLERIAN INHIBITING SUBSTANCE ANTIBODIES AND USES THEREOF
#111Anti-PACAP antibodies and uses thereof
#112KIT AND METHOD FOR COMBINED DETECTION OF PCT AND PRESEPSIN, AND USE THEREOF
#113Long-Acting Therapeutic Fusion Proteins
#114METHODS AND COMPOSITIONS FOR TREATMENT OF ENDOTHELIN B RECEPTOR EXPRESSING TUMORS
#115PROVASOPRESSIN ANTAGONISTS AND USES THEREOF
#116Method for controlling affinity of antibody for antigen, antibody whose affinity for antigen has been altered, and its production method
#117METHOD FOR IMPROVING AFFINITY OF ANTIBODY FOR ANTIGEN AND USE THEREOF
#118NOVEL MODULATORS
#119IDENTIFICATION OF A NEW POLYPEPTIDE HORMONE FOR MAINTENANCE OF OPTIMAL BODY WEIGHT AND BLOOD GLUCOSE
#120Method for improving affinity of antibody for antigen and use thereof
#121MONOCLONAL ANTIBODIES TO PROGASTRIN AND THEIR USES
#122NEUTRALIZING ANTIBODIES TO HUMAN ENDOTHELIN
#123Polynucleotides encoding monoclonal antibodies binding to human pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and methods of making thereof
#124NUCLEIC ACIDS ENCODING ANCHOR MODIFIED ANTIBODIES AND USES THEREOF
#125ION CONCENTRATION-DEPENDENT BINDING MOLECULE LIBRARY
#126PROTEIN PURIFICATION METHOD
#127SPECIFIC ANTIBODY AGAINST HUMAN ANTI-MULLERIAN HORMONE AND APPLICATION THEREOF
#128ILT7 binding molecules and methods of using the same
#129Leptin immunogens, hybridoma cells, monoclonal antibodies, polyclonal antibodies and use thereof
#130VARIANTS OF ERYTHROFERRONE AND THEIR USE
#131Anti-CGRP Antibody Formulation
#132POLYCLONAL-MONOCLONAL ELISA ASSAY FOR DETECTING N-TERMINUS PRO-BNP
#133MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
#134HUMANIZED ANTI-ACTH ANTIBODIES AND USE THEREOF
#135ANTIBODIES AND USE THEREOF
#136Methods and agents to treat tumor cells and cancer
#137MONOCLONAL ANTIBODIES AGAINST ENDOTROPHIN AND THE USE THEREOF
#138Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using Same
#139METHOD OF TREATMENT TO PREVENT OR REVERSE AGE-ASSOCIATED INFLAMMATION, COGNITIVE DECLINE, AND NEURODEGENERATION
#140PREVENTING, TREATING, AND REDUCING (PERSISTENT) POST-TRAUMATIC HEADACHE
#141Highly sensitive particle enhanced assay for the quantification of NT-proBNP
#142ACTRIIB PROTEINS AND VARIANTS AND USES THEREFORE RELATING TO UTROPHIN INDUCTION FOR MUSCULAR DYSTROPHY THERAPY
#143Cancer associated antibody compositions and methods of use
#144Protein signatures for distinguishing between bacterial and viral infections
#145METHODS FOR DECREASING INFLUENZA-INDUCED LETHALITY USING GASTRIN-RELEASING PEPTIDE (GRP) INHIBITORS OR GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR) ANTAGONISTS
#146Weight loss regimen
#147NOVEL T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME
#148METHODS OF DETERMINING WHETHER ANTI-PACAP ANTIBODIES INHIBIT PACAP-ASSOCIATED PHOTOPHOBIA OR LIGHT AVERSION
#149Compositions and methods for assessing the risk of cancer occurrence
#150Materials and methods for treating stress-related disorders and cancer
#151COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING EPO
#152COMPOSITIONS AND METHODS FOR TREATING ISCHEMIC HEART DISEASE
#153Method for treating pulmonary hypertension with antibodies to human Resistin
#154Systems and Methods for Detecting or Monitoring Insulin
#155Combination therapy between anti-progastrin antibody and immunotherapy to treat cancer
#156Screening method for identifying anti-PACAP antibodies or antibody fragments suitable for use in treating or preventing PACAP-associated photophobia or light aversion
#157Methods of Treating Chronic Pain
#158Methods and Compositions for Treating Aging-Associated Impairments with Trefoil Factor Family Member 2 Modulators
#159Methods of treatment with anti-PACAP antibodies
#160METHOD OF MODULATING THE CONCENTRATION OF PROTEINS IN CEREBROSPINAL FLUID
#161METHOD FOR IMPROVING AFFINITY OF ANTIBODY FOR ANTIGEN AND USE THEREOF
#162TREATMENTS RELATED TO GH/IGF-1 AXIS INHIBITION
#163MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
#164Anti-thyroid hormone (T4) recombinant antibody or antigen binding fragment
#165Methods of treating severe insulin resistance by interfering with glucagon receptor signaling
#166ANTI-PACAP ANTIBODIES
#167Methods of Treating Metabolic Disease
#168MONOCLONAL ANTIBODY FUSIONS
#169Leptin antibodies
#170Treatment of headache, migraine and/or photophobia conditions using humanized anti-PACAP antibodies
#171Methods and Compositions for Treating Aging-Associated Impairments with Trefoil Factor Family Member 2 Modulators
#172COMPOUNDS USEFUL TO TREAT METABOLIC DISORDERS
#173Human endothelin receptor antibody and use thereof
#174Methods for Improving Leptin Sensitivity for the Treatment of Obesity and Diabetes
#175NEUROMODULATING COMPOSITIONS AND RELATED THERAPEUTIC METHODS FOR THE TREATMENT OF CANCER BY MODULATING AN ANTI-CANCER IMMUNE RESPONSE
#176Methods of treating a wasting syndrome, increasing growth hormone levels, and increasing GHSR activity with a LEAP2 antibody
#177PACAP antibodies and uses thereof
#178Methods of screening antigen-binding molecules by normalizing for the concentration of antigen-binding molecule
#179Compositions and methods for detecting and treating prostate cancer using progastrin binding molecule
#180Compositions and methods for treating lung cancer
#181Methods and means for the production of Ig-like molecules
#182Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles
#183ASPROSIN, A FAST-INDUCED GLUCOGENIC PROTEIN HORMONE
#184METHODS FOR TREATING VISCERAL PAIN BY ADMINISTERING ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDE
#185ANTI-CGRP COMPOSITIONS AND USE THEREOF
#186Antigenic peptides deriving from urocortin 3 and uses thereof for the diagnosis and treatment of type 1 diabetes
#187DERMAL PATCH FOR TRANSDERMAL ADMINISTRATION OF GHRELIN PATHWAY BLOCKER
#188Compositions for and methods of diagnosing, prognosing, and treating diabetes
#189MULTIVALENT MONO- OR BISPECIFIC RECOMBINANT ANTIBODIES FOR ANALYTIC PURPOSE
#190Methods for treating a headache condition using anti-human PAC1 antibodies or antigen-binding fragments thereof
#191Combination therapy between anti-progastrin antibody and immunotherapy to treat cancer
#192Anti-neurotensin long fragment antibodies and uses thereof
#193Antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like peptide 1 receptors
#194MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
#195Stable Dual Variable Domain Immunoglobulin Protein Formulations
#196METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING ANTAGONISTIC BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR)/GLP-1 RECEPTOR AGONIST FUSION PROTEINS
#197Polynucleotides encoding relaxin
#198Anti-Marinobufagenin Antibodies and Uses Thereof
#199ILT7 binding molecules and methods of using the same
#200Methods of treating inflammatory skin disorders
#201METHODS FOR TREATING PSORIASIS
#202NARCOLEPSY-SPECIFIC MARKERS
#203Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereof
#204Anti-ACTH antibodies and use thereof
#205Methods and compositions for treatment of endothelin B receptor expressing tumors
#206METHODS AND COMPOSITIONS FOR INCREASING ENZYME ACTIVITY IN THE CNS
#207Antibodies and use thereof
#208Methods and systems for detecting peptide aggregates
#209KITS FOR DETECTION OF HEPCIDIN
#210ADRENOMEDULLIN TO GUIDE THERAPY OF BLOOD PRESSURE DECLINE
#211Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using Same
#212Antibodies to human erythroferrone and uses thereof
#213NOVEL COMPOUNDS CAPABLE OF ANTAGONIZING ISLET AMYLOID POLYPEPTIDE (IAPP) INDUCED BETA-CELL DAMAGE AND IMPAIRED GLUCOSE TOLERANCE
#214PROTEIN PURIFICATION METHOD
#215Compositions and methods for detecting prostate cancer
#216Recombinant FSH composition for controlled ovarian stimulation
#217Humanized anti-PACAP antibodies
#218Humanized anti-PACAP antibodies
#219Anti-PACAP antibodies
#220Humanized anti-ACTH antibodies and use thereof
#221Humanized anti-PACAP antibodies
#222Compositions and methods for treating obesity and hyperphagia
#223PREVENTING, TREATING, AND REDUCING (PERSISTENT) POST-TRAUMATIC HEADACHE
#224ION EXCHANGE CHROMATOGRAPHY WITH IMPROVED SELECTIVITY FOR THE SEPARATION OF POLYPEPTIDE MONOMERS, AGGREGATES AND FRAGMENTS BY MODULATION OF THE MOBILE PHASE
#225T cell receptors and immune therapy using the same
#226MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
#227Immunoassay for human erythroferrone
#228METHODS FOR TREATING INFLAMMATION USING ANTIBODIES TO KALLIDIN AND DES-ARG10-KALLIDIN
#229Compositions and methods for detecting lung cancer
#230Anti-thyroglobulin T cell receptors
#231METHODS OF TREATING CHRONIC PAIN
#232Anti-PACAP antibodies
#233TREATMENT OF OBESITY AND EATING DISORDERS
#234Methods for detecting 1,25-dihydroxyvitamin D and related antibodies
#235Bi-specific antibodies and uses thereof
#236COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING EPO
#237Methods and means for the production of ig-like molecules
#238IMMUNOASSAY METHOD USING ANTI-HUMAN BNP FRAGMENT (4-32) ANTIBODY
#239Regulation of glucose metabolism using anti-CGRP antibodies
#240Monoclonal antibodies to progastrin and their uses
#241Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles
#242Antibody Compositions and Immunoassay Methods to Detect Isoforms of Anti-Müllerian Hormone
#243Anti-marinobufagenin antibodies and uses thereof
#244Antibodies recognizing genetic variants of NT-proBNP
#245Human endothelin receptor antibody and use thereof
#246Methods for treating psoriasis
#247USES OF MODIFIED MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
#248Motor control function improving agent
#249Cognitive function improving agent
#250Hypothermia Ameliorating Agent
#251Antibodies that bind to human anti-Müllerian hormone (AMH) and their uses
#252INSULIN GENE-DERIVED PROTEINS AND PEPTIDES FOR USE IN THE DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES
#253Compositions and methods for treating ischemic heart disease
#254ACRIDINE LABELLED CONJUGATES AND PREPARATION METHODS THEREFOR AND CHEMILUMINESCENT KITS
#255ERFE SPECIFIC ANTIBODIES COMPOSITIONS AND METHODS OF USE
#256METHODS FOR STIMULATION OF APPETITE AND INCREASE IN WEIGHT BY ADMINISTRATION OF ASPROSIN
#257BLOCKERS OF THE GROWTH HORMONE RECEPTOR IN DISEASE PREVENTION AND TREATMENT
#258Methods of determining whether anti-PACAP antibodies inhibit PACAP-associated photophobia or light aversion
#259Allosteric split trehalase biosensor
#260T cell receptors and immune therapy using the same
#261Mitigating Tissue Damage and Fibrosis Via Latent Transforming Growth Factor Beta Binding Protein (LTBP4)
#262PURIFICATION OF MULTISPECIFIC ANTIBODIES
#263Anti-PD-L1-anti-TIM-3 bispecific antibodies
#264Compositions and methods for reducing adiposity by inhibiting FSH/FSHR
#265Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels
#266NEUROMODULATING COMPOSITIONS AND RELATED THERAPEUTIC METHODS FOR THE TREATMENT OF CANCER BY MODULATING AN ANTI-CANCER IMMUNE RESPONSE
#267Anti-PACAP antibodies and uses thereof
#268Methods of treating severe insulin resistance by interfering with glucagon receptor signaling
#269Compositions and methods for measuring NMU and for treatment using anti-NMU agents
#270Long-Acting Therapeutic Fusion Proteins
#271PAC1 antibodies and uses thereof
#272Method for preparing anti-AMH antibodies and uses of same
#273Anti-CGRP compositions and use thereof
#274Anti-LPS Enriched Immunoglobulin Preparation for Use in the Treatment and/or Prophylaxis of a Pathologic Disorder
#275Antibodies to TTR and methods of use
#276Cortistatin analogues and syntheses and uses thereof
#277LONG LIFE POLYPEPTIDE BINDING MOLECULES
#278Methods and agents to treat tumor cells and cancer
#279Modular, controlled single chain variable fragment antibody switch
#280ASPROSIN, A FAST-INDUCED GLUCOGENIC PROTEIN HORMONE
#281Quantitative profiling of progesterone metabolites for the prediction of spontaneous preterm delivery
#282Compositions and methods for antibodies targeting EPO
#283COMPOUNDS USEFUL TO TREAT METABOLIC DISORDERS
#284Protein signatures for distinguishing between bacterial and viral infections
#285Methods of treating fibromyalgia
#286SIGNAL BIOMARKERS
#287cgb2 And cgb1 Genes; Diagnosis, Monitoring And Treatment Of Cancer
#288Method of modulating the adrenomedullin (ADM) activity of a patient by administering to the patient an anti-ADM antibody or fragment thereof that specifically binds to mature human ADM
#289Anti-CGRP compositions and use thereof
#290Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using Same
#291Humanized anti-ACTH antibodies and use thereof
#292Methods for treating visceral pain associated with interstitial cystitis by administering antagonist antibodies directed against calcitonin gene-related peptide
#293IGF-1R monoclonal antibodies and uses thereof
#294Anti-neurotensin long fragment antibodies and uses thereof
#295Kit and method for measuring prostaglandin E-major urinary metabolite
#296Antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like peptide 1 receptors
#297ASSAYS FOR B-TYPE NATRIURETIC PEPTIDE ANALOGUES RESISTANT TO PROLYL-SPECIFIC DIPEPTIDYL DEGRADATION
#298METHOD FOR IDENTIFYING BIOACTIVE PROTEIN, AND BIOACTIVE PROTEIN OBTAINED BY SAID METHOD
#299IMMUNOASSAY FOR THE DETECTION OF PROCALCITONIN
#300Method to screen high affinity antibody